| 000 | 01683 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513061250.0 | ||
| 264 | 0 | _c19930709 | |
| 008 | 199307s 0 0 eng d | ||
| 022 | _a0026-0495 | ||
| 024 | 7 |
_a10.1016/0026-0495(93)90244-i _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLonghurst, P A | |
| 245 | 0 | 0 |
_aThe influence of diabetes mellitus on glucose utilization by the rat urinary bladder. _h[electronic resource] |
| 260 |
_bMetabolism: clinical and experimental _cJun 1993 |
||
| 300 |
_a749-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBethanechol |
| 650 | 0 | 4 |
_aBethanechol Compounds _xpharmacology |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aExtracellular Space _xmetabolism |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 |
_aPhosphocreatine _xmetabolism |
| 650 | 0 | 4 |
_aPyruvates _xpharmacology |
| 650 | 0 | 4 | _aPyruvic Acid |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
| 700 | 1 | _aBriscoe, J A | |
| 700 | 1 | _aLeggett, R E | |
| 700 | 1 | _aSamadzadeh, S | |
| 700 | 1 | _aLevin, R M | |
| 773 | 0 |
_tMetabolism: clinical and experimental _gvol. 42 _gno. 6 _gp. 749-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0026-0495(93)90244-i _zAvailable from publisher's website |
| 999 |
_c8099027 _d8099027 |
||